267 related articles for article (PubMed ID: 26458382)
1. Therapies on the Horizon for Diabetic Kidney Disease.
Khan SS; Quaggin SE
Curr Diab Rep; 2015 Dec; 15(12):111. PubMed ID: 26458382
[TBL] [Abstract][Full Text] [Related]
2. Suppressors of cytokine signaling abrogate diabetic nephropathy.
Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
[TBL] [Abstract][Full Text] [Related]
3. New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy.
Brosius FC
Rev Endocr Metab Disord; 2008 Dec; 9(4):245-54. PubMed ID: 18726161
[TBL] [Abstract][Full Text] [Related]
4. JAK inhibition and progressive kidney disease.
Brosius FC; He JC
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):88-95. PubMed ID: 25415616
[TBL] [Abstract][Full Text] [Related]
5. Evolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward.
Blumenthal SS
Postgrad Med; 2011 Nov; 123(6):166-79. PubMed ID: 22104465
[TBL] [Abstract][Full Text] [Related]
6. Diabetic nephropathy: where hemodynamics meets metabolism.
Forbes JM; Fukami K; Cooper ME
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in diabetic nephropathy.
Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta in diabetic kidney disease: role of novel signaling pathways.
Sharma K; McGowan TA
Cytokine Growth Factor Rev; 2000; 11(1-2):115-23. PubMed ID: 10708959
[TBL] [Abstract][Full Text] [Related]
9. Update of pathophysiology and management of diabetic kidney disease.
Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia to nephropathy via transforming growth factor beta.
Garud MS; Kulkarni YA
Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
[TBL] [Abstract][Full Text] [Related]
11. A new pair of SOCS for diabetic nephropathy.
Brosius FC; Banes-Berceli A
J Am Soc Nephrol; 2010 May; 21(5):723-4. PubMed ID: 20413610
[No Abstract] [Full Text] [Related]
12. Role of the JAK/STAT signaling pathway in diabetic nephropathy.
Marrero MB; Banes-Berceli AK; Stern DM; Eaton DC
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F762-8. PubMed ID: 16527921
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies in diabetic nephropathy: an update.
Gupta A; Gupta P; Biyani M
J Nephrol; 2011; 24(6):686-95. PubMed ID: 22058027
[TBL] [Abstract][Full Text] [Related]
14. Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.
Patel DM; Bose M; Cooper ME
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210089
[TBL] [Abstract][Full Text] [Related]
15. KCa3.1: a new player in progressive kidney disease.
Huang C; Pollock CA; Chen XM
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):61-6. PubMed ID: 25415613
[TBL] [Abstract][Full Text] [Related]
16. Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model.
Ji ZZ; Xu YC
Mol Med Rep; 2016 Jul; 14(1):920-6. PubMed ID: 27220903
[TBL] [Abstract][Full Text] [Related]
17. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
Elmarakby AA; Sullivan JC
Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
19. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy.
Leon CA; Raij L
J Hypertens; 2005 Nov; 23(11):1931-7. PubMed ID: 16208129
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.
Berthier CC; Zhang H; Schin M; Henger A; Nelson RG; Yee B; Boucherot A; Neusser MA; Cohen CD; Carter-Su C; Argetsinger LS; Rastaldi MP; Brosius FC; Kretzler M
Diabetes; 2009 Feb; 58(2):469-77. PubMed ID: 19017763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
